Chemotherapy Drugs Current Events | Chemotherapy Drugs News | 3
|
| Page
3 of
55 |
1084 Results |
|
|
|
Sort By:
Page Views | Date |
New hope for deadly childhood bone cancer
Researchers at Huntsman Cancer Institute (HCI) at the University of Utah have shed new light on Ewing's sarcoma, an often deadly bone cancer that typically afflicts children and young adults. view more (2009-08-31)
Researchers Discover New Method to Treat Cancer
Research at Oxford University's Institute of Molecular Medicine has identified a novel therapeutic regimen for the treatment of cancer that provides significant advantages over the existing methods of cancer treatment. There are already a number of regimens available for treatment of cancer, including chemotherapy, which is commonly used to treat... view more... (2003-03-20)
Enhancing chemotherapy's efficacy: new agent has synergistic effect with standard drugs
Integrating the use of drugs targeted to specific cancer proteins into current chemotherapy regimens to improve the efficacy of systemic treatment is an important clinical goal at Fox Chase Cancer Center. view more (2007-04-16)
Tumor mutations can predict chemo success
New work by MIT cancer biologists shows that the interplay between two key genes that are often defective in tumors determines how cancer cells respond to chemotherapy. view more (2009-08-07)
HtrA1 and resistance to chemotherapy in ovarian and gastric cancers
While many cancer patients initially have a favorable response to chemotherapy for the treatment of solid tumors, resistance to treatment often develops. view more (2006-06-09)
Low-dose chemotherapy plus antiangiogenesis drug has activity in advanced breast cancer
Chemotherapy given in low, frequent doses - a novel strategy called "metronomic" delivery - achieved partial shrinkage of disease in some advanced breast cancer patients when given concurrently with an angiogenesis inhibitor. view more (2005-12-09)
Combined Chemotherapy and Radiotherapy for Cervical Cancer Could Increase Survival (p 781)
A systematic review of randomised trials in the past two decades published in this week’s issue of THE LANCET concludes that women given concurrent chemotherapy and radiotherapy for cervical cancer could have an increased survival-rate of 12% compared with patients treated with radiotherapy alone. Cervical cancer is the second most common... view more... (2001-09-05)
U-M study finds voice box can be preserved, even with the largest cancers
Some patients with large tumors on their larynx can preserve their speech by opting for chemotherapy and radiation over surgery to remove the voice box. view more (2009-06-26)
McGill researchers overcome chemotherapy resistance in the lab
Researchers from McGill University's Faculty of Medicine have discovered a compound that reduces resistance to chemotherapy agents used to treat cancer. Their results were published in the June issue of The Journal of Clinical Investigation (JCI). view more (2008-06-30)
New genomic tests guide choice of chemotherapy in cancer patients
Scientists at Duke University's Institute for Genome Sciences & Policy have developed a panel of genomic tests that analyzes the unique molecular traits of a cancerous tumor and determines which chemotherapy will most aggressively attack that patient's cancer. view more (2006-10-23)
Cancer drugs my build and not tear down blood vessels
Scientists have thought that one way to foil a tumor from generating blood vessels to feed its growth - a process called angiogenesis - was by creating drugs aimed at stopping a key vessel growth-promoting protein. But now the opposite seems to be true. view more (2008-11-10)
Pre-clinical studies identify novel ways to enhance effect of chemotherapy
Results call for clinical trials with Glivec in combination with other chemotherapy Frankfurt, Germany: Researchers have found that blocking the action of a growth factor on tumour stroma cells[1] increases the uptake of cancer drugs by the tumour. The findings could be crucial for efforts to make standard chemotherapy work better. Kristian... view more... (2002-11-17)
Novel mechanism of taxane resistance
Research Associate Chih-Jian Lih and others working in the laboratory of Dr. Stanley N. Cohen at Stanford University have pinpointed a gene that affects human cancer cells' sensitivity to chemotherapy-an important finding in the effort to increase the effectiveness of chemotherapy. view more (2006-07-17)
Jefferson researchers show chemotherapy and radiation together extend lung cancer patients' lives
Chemotherapy given at the same time as radiation therapy can help patients with a certain type of lung cancer live nearly 50 percent longer than they might have otherwise if the same treatment was given differently, according to an international team's analysis of several trial results. view more (2007-11-12)
Benefits Outweigh Burden Of Chemotherapy After Breast Cancer (P 277)
The benefits of adjuvant chemotherapy for breast cancer outweigh its side-effects, especially for younger women, conclude authors of a study in this week's issue of THE LANCET. Previous randomised trials have shown that prolonged chemotherapy for breast cancer substantially reduces the risk of disease relapse and death compared with no... view more... (2001-07-25)
Chemotherapy and tamoxifen reduce risk of second breast cancer
Among breast cancer patients, both chemotherapy and tamoxifen independently reduced the risk of developing a second cancer in the other breast, according to a study published online December 25 in the Journal of the National Cancer Institute. The risk reduction persisted for at least 10 and 5 years, respectively. view more (2007-12-26)
Is milk thistle effective in cancer treatment?
Milk thistle extract, an herbal remedy since the times of the ancient Greeks and Romans, is today one of the most popular herbal supplements, with U.S. retail sales of nearly nine million dollars. view more (2007-07-11)
Stealth particles to target tumors
Stealth nano particles may some day target tumor cells and deliver medication to specific body locations, according to Penn State chemical engineers. view more (2005-09-01)
Targeted therapy plus chemotherapy may pack 1-2 punch against melanoma
By targeting and disabling a protein frequently found in melanoma tumors, doctors may be able to make the cancer more vulnerable to chemotherapy, according to a new study by researchers in the Duke Comprehensive Cancer Center. view more (2008-05-15)
Adding cetuximab to chemotherapy reduces advanced lung cancer death risk by 13 percent
Patients with advanced non-small cell lung cancer who are given cetuximab (Erbitux) in addition to chemotherapy are 13% less likely to die than those who receive chemotherapy alone, regardless of which chemotherapy drug cocktail is used, new research finds. They also experience slower disease progression and an increased chance of tumour shrinkage. view more (2009-09-22)
|
|
| Page
3 of
55 |
1084 Results |
|
|
|
Sort By:
Page Views | Date |
|
